K R Lamborn

Glioblastoma Patients Epidermal Growth Factor Receptor , and Survival in Analysis of Complex Relationships between Age , p 53 , Updated

Susan M. Chang, T. Godfrey, K. Aldape, 2001 .

Increased survival associated with radiolabeled lym‐1 therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia

G L DeNardo, K. Lamborn, G. Denardo, 1997, Cancer.

Radiation response and survival time in patients with glioblastoma multiforme.

M. Prados, M. McDermott, P. Gutin, 1996, Journal of neurosurgery.

A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.

S Shen, G L DeNardo, K. Lamborn, 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.

T L Phillips, P R Stauffer, Susan M. Chang, 1998, International journal of radiation oncology, biology, physics.

Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome.

M. Berger, G. E. Keles, K. Lamborn, 2001, Journal of neurosurgery.